gps tracking by cell phone number parental phone tracking iphone 4s spy video app best spy app for rooted android best free undetectable spy software for android

bottene faq COR

A treatment that has recently become available in Brazil promises to treat some of the undesirable effects of the menopause. 

This treatment is a CO2 fractional laser, specially designed for vaginal atrophy.  This condition affects up to half of all menopausal women and is characterised by the loss of lubrication and elasticity in the mucus membrane of the vagina and pain during sexual intercourse

Atrophy is caused by an oestrogen deficiency during menopause, and is generally treated with oestrogen based creams.

According to the manufacturer, the apparatus successfully restores the elasticity, thickness and moisture of the vagina by stimulating collagen production and could be an option for patients who are advised not to use hormonal creams due to a history of breast cancer. 

Currently, women with this profile have the option of polyacrylic acid, which forms a layer that covers the mucus membrane of the vagina and leads to hydration, although not as effectively as with hormone creams, and one specific oestrogen based cream that has a local action and a lower absorption rate. 

This last treatment, however, must be discussed by the doctor and patient and is not without risks. 
Gynaecologist Vera Lucia da Cruz, professor at the ABC School of Medicine, began using laser therapy in her private clinic and confirms that the treatment is painless and causes no discomfort. In her opinion, it may be necessary to have up to three sessions per year.

One of her patients, who wished to remain anonymous, confirms that she was satisfied with the treatment.  She reports feeling no discomfort.  "I felt as if something was moving, but it was quick and less uncomfortable than a smear test." At age 60 and with an active sex life, she says she has noticed a considerable improvement during sexual intercourse.  "I began to feel more pleasure; it increased my self esteem. Before it was painful and troublesome, it had stopped being enjoyable."

Approved by ANVISA last year, the MonaLisa Touch laser will be the subject of two studies at the ABC School of Medicine, under the coordination of Professor Vera Lucia da Cruz.
One study will aim to compare traditional treatments (oestrogen based creams) with the new laser. The other will test the laser on young women who have undergone premature menopause, after receiving treatment for cancer.

According to César Fernandes, President of SOGESP (Association of Obstetrics and Gynaecology in the State of São Paulo), the description and effects of the laser treatment are well-founded, but further studies are necessary.
"I would like to see research that reinforces existing evidence, with a greater number of patients, comparisons with conventional treatments, and results showing long term efficacy and safety," he affirmed.